Atlas Trials

Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCC

Clinical trial NCT03744247 · WITHDRAWN

Trial details

NCT number
NCT03744247
Sponsor
Sun Yat-sen University
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2019-04-21
Primary completion
2021-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.